IN2014DN11040A - - Google Patents
Info
- Publication number
- IN2014DN11040A IN2014DN11040A IN11040DEN2014A IN2014DN11040A IN 2014DN11040 A IN2014DN11040 A IN 2014DN11040A IN 11040DEN2014 A IN11040DEN2014 A IN 11040DEN2014A IN 2014DN11040 A IN2014DN11040 A IN 2014DN11040A
- Authority
- IN
- India
- Prior art keywords
- beads
- dosage form
- particles
- comparative
- binder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/531,955 US8722083B2 (en) | 2012-06-25 | 2012-06-25 | Fenofibrate formulation |
| PCT/US2012/061486 WO2014003810A1 (en) | 2012-06-25 | 2012-10-23 | Fenofibrate formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN11040A true IN2014DN11040A (cg-RX-API-DMAC7.html) | 2015-09-25 |
Family
ID=49774658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN11040DEN2014 IN2014DN11040A (cg-RX-API-DMAC7.html) | 2012-06-25 | 2012-10-23 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8722083B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2863894B1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014032513B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2878011A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2842500T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DN11040A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014003810A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9439860B2 (en) * | 2012-06-25 | 2016-09-13 | Mylan, Inc. | Fenofibrate formulation |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2602423B1 (fr) | 1986-08-08 | 1989-05-05 | Ethypharm Sa | Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede |
| FR2627696B1 (fr) | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| FR2758459B1 (fr) | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
| US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| WO2000052136A2 (en) * | 1999-03-02 | 2000-09-08 | Human Genome Sciences, Inc. | Human glycosylation enzymes |
| US7863331B2 (en) | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| FR2795961B1 (fr) | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
| TWI293877B (en) | 2000-09-20 | 2008-03-01 | Rtp Pharma Inc | Spray drying process and compositions of fenofibrate |
| US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
| US20080241070A1 (en) | 2000-09-21 | 2008-10-02 | Elan Pharma International Ltd. | Fenofibrate dosage forms |
| BRPI0513082A (pt) | 2004-08-06 | 2008-04-22 | Transform Pharmaceuticals Inc | formulações de fenofibrato e métodos de tratamento relacionados |
| EP1853249A2 (en) | 2005-02-10 | 2007-11-14 | LifeCycle Pharma A/S | A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor |
| EP2068837A2 (en) * | 2006-07-28 | 2009-06-17 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
| WO2008075320A2 (en) * | 2006-12-21 | 2008-06-26 | Ranbaxy Laboratories Limited | Antilipidemic pharmaceutical compositions and process for preparation thereof |
| EP2192892A2 (en) | 2007-07-27 | 2010-06-09 | Depomed, Inc. | Pulsatile gastric retentive dosage forms |
| FR2940118B1 (fr) | 2008-12-24 | 2013-08-09 | Ethypharm Sa | Formulation pharmaceutique de fenofibrate nanonise |
| US20100166857A1 (en) * | 2008-12-30 | 2010-07-01 | Dong Yan | Pharmaceutical dosage forms and methods of manufacturing same |
| US20110217369A1 (en) * | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
| US20110311625A1 (en) | 2010-06-14 | 2011-12-22 | Amruth Gowda Doddaveerappa | Solid dosage forms of fenofibrate |
-
2012
- 2012-06-25 US US13/531,955 patent/US8722083B2/en not_active Expired - Fee Related
- 2012-10-23 ES ES12879875T patent/ES2842500T3/es active Active
- 2012-10-23 BR BR112014032513-8A patent/BR112014032513B1/pt active IP Right Grant
- 2012-10-23 CA CA2878011A patent/CA2878011A1/en not_active Abandoned
- 2012-10-23 EP EP12879875.8A patent/EP2863894B1/en active Active
- 2012-10-23 WO PCT/US2012/061486 patent/WO2014003810A1/en not_active Ceased
- 2012-10-23 IN IN11040DEN2014 patent/IN2014DN11040A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2863894B1 (en) | 2020-10-14 |
| US20130344155A1 (en) | 2013-12-26 |
| WO2014003810A1 (en) | 2014-01-03 |
| EP2863894A4 (en) | 2015-12-16 |
| US8722083B2 (en) | 2014-05-13 |
| CA2878011A1 (en) | 2014-01-03 |
| BR112014032513B1 (pt) | 2020-06-30 |
| BR112014032513A2 (pt) | 2017-06-27 |
| EP2863894A1 (en) | 2015-04-29 |
| ES2842500T3 (es) | 2021-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595985A (en) | A novel formulation of naproxen | |
| NZ742005A (en) | Pharmaceutical nanoparticles showing improved mucosal transport | |
| PH12015500301A1 (en) | A novel formulation of diclofenac | |
| WO2011159792A3 (en) | High roll density fibrous structures | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| MY159208A (en) | A novel formulation of indomethacin | |
| EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
| MX350545B (es) | Partículas de suministro con pluralidad de núcleos. | |
| EP2571486A4 (en) | DRY POWDER INHALATION COMPOSITION | |
| MX2017006858A (es) | Composición farmacéutica o nutracéutica con resistencia a la influencia del etanol. | |
| PH12015500172A1 (en) | Novel rebamipide prodrugs, preparation method and use thereof | |
| MY174729A (en) | Pharmaceutical combination drug | |
| MX363699B (es) | Producto de comicronizacion que comprende acetato de ulipristal. | |
| NZ603199A (en) | Orally disintegrating tablet containing acarbose | |
| GB201210060D0 (en) | Composition | |
| WO2011139256A3 (en) | Stable rosuvastatin formulations | |
| WO2014144407A8 (en) | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof | |
| TW201129386A (en) | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | |
| MX359713B (es) | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. | |
| IN2014DN09416A (cg-RX-API-DMAC7.html) | ||
| AU2014226192A8 (en) | Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles | |
| MX2013013079A (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
| IN2014DN11040A (cg-RX-API-DMAC7.html) | ||
| ZA201404068B (en) | The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents | |
| WO2015024577A3 (fr) | Composition a base de safranal |